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Abstract
Background: Studies have implicated reduced levels of brain-derived neurotrophic factor (BDNF) in the
pathogenesis of Huntington’s disease. Mutant huntingtin (Htt) protein was previously reported to decrease BDNF
gene transcription and axonal transport of BDNF. We recently showed that wild-type Htt is associated with the
Argonaute 2 microRNA-processing enzyme involved in gene silencing. In dendrites, Htt co-localizes with
components of neuronal granules and mRNAs, indicating that it might play a role in post-transcriptional
processing/transport of dendritic mRNAs.
Results: We conducted imaging experiments in cultured cortical neurons to demonstrate the co-localization of
endogenous Htt and BDNF mRNA in fixed cells, and co-trafficking of BDNF 3’UTR mRNA with endogenous and
fluorescently tagged Htt in live neurons. We used an enhanced technique that combines FISH and
immunofluorescent staining to co-localize BDNF mRNA with Htt, Ago2, CPEB and dynein in thick vibratome
sections of the rat cortex.
Conclusions: In cultured neurons and sections of the rat cortex, we found BDNF mRNA associated with Htt and
components of neuronal RNA granules, which are centers for regulating RNA transport and local translation. Htt
may play a role in post-transcriptional transport/targeting of mRNA for BDNF, thus contributing to neurotrophic
support and neuron survival.
Background
Huntington’s disease (HD) protein huntingtin (Htt) is a
350 kDa protein widely expressed at high levels in the
hippocampus, cortex, cerebellum and striatum. Expan-
sion of a triplet CAG repeat sequence in the 5’ end of
the Htt gene generates a protein with poly-glutamine
repeat expansion, which is the cause of HD, an autoso-
mal dominant neurodegenerative disorder characterized
by uncontrolled movements, personality changes,
dementia and death [reviewed in [1,2]]. Although the
pathogenesis of HD involves many processes, current
evidence suggests significant dysfunction of neurons
leading to progressive neuronal loss initially in the stria-
tum. The ubiquitous expression of Htt does not provide
an explanation for the selective striatal cell neurodegen-
eration at the onset of HD. Wild-type Htt has been
implicated in many cellular functions including regula-
tion of gene expression, endocytosis and microtubule-
directed vesicular trafficking in axons and dendrites
[reviewed in [3]]. Several studies have linked brain-
derived neurotrophic factor (BDNF) with HD [reviewed
in [4]], and hence, it is a possible therapeutic target for
the disease [5,6]. Transcription of BDNF is reported
deregulated in HD, and transport of BDNF secretory
vesicles necessary for neuronal survival requires a func-
tional Htt [7,8].
Recently, we have localized Htt with the small RNA-
associated protein Argonaute 2 (Ago2) in processing
(P)-bodies from somatic cells [9], and in neuronal RNA
granules involved in transport and local translation of
mRNA in dendrites [10]. Because Ago2 has specific roles
in RNA processing and gene silencing in restricted
domains of the cell, the association with Htt in ribonu-
cleoprotein particles (P-bodies and neuronal granules)
provides a possible mechanism to account for the trans-
port and translation of specific mRNAs. There are
many potential genes that may be controlled at a post-
transcriptional level by Ago2 and Htt. Because multiple
isoforms of BDNF mRNA are transported to dendrites
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any medium, provided the original work is properly cited.[11,12], we hypothesized that Htt, in association with
Ago2, might regulate BDNF mRNA processing and/or
trafficking.
Results
Huntingtin co-localizes with BDNF mRNA in cortical
neurons
We recently reported that Htt associates with compo-
nents of neuronal RNA granules and contributes to
transport of mRNA in dendrites [10]. Purification of
endogenous Htt from mouse brain extracts demon-
strated presence of Ago2 protein as well as brain-speci-
fic mRNAs such as IP3R1, CaMKIIa and MAP2. The
BDNF gene encodes for multiple alternatively spliced
transcripts that target different dendritic compartments
[13]. Significantly, the G196A mutation in the BDNF
gene associated with neuropsychiatric disorders was
found to block dendritic targeting by altering the bind-
ing site for the RNA binding protein translin which
mediates dendritic targeting [13]. Because BDNF levels
are reduced in the brains of HD patients and HD mouse
models, we sought to investigate whether Htt might be
involved in the transport of BDNF mRNA through neu-
ronal RNA granules.
To localize Htt and BDNF mRNA, rat cortical neurons
(DIV 8) were stained for endogenous Htt with an antibody
to Htt (MAB2166, Millipore). The specificity of the anti-
body was first determined by western blotting of mouse
brain fractions prepared by sequential centrifugation of
total brain homogenate (see Methods). Probing with
MAB2166 demonstrated highly specific and broad subcel-
lular distribution of endogenous full-length Htt (Fig. 1a).
Furthermore, knockdown of Htt by shRNA resulted in
loss of the immunoreactive band, and reduced immunos-
taining of Htt in cortical neurons [10]. Htt-/- ES cells
showed no detectable immunoreactivity when stained with
MAB2166 [10]. Therefore, we find MAB2166 antibody to
be highly specific to endogenous Htt in rodent neurons.
We next detected BDNF mRNA in cortical neurons by
fluorescent in situ hybridization (FISH) using the BDNF
coding sequence as probe (Fig. 1b). The BDNF mRNA
was visualized in the form of RNA granules, which may
contain multiple (up to 30) RNA molecules [14,15]. We
found BDNF mRNA to co-localize with Htt in granules,
consistent with our previous finding that Htt is present
in neuronal RNA granules and co-localizes with
mRNAs [10].
Co-localization of Htt with BDNF-3’UTR mRNA in cortical
neurons
To examine further the association of Htt with BDNF
mRNA in neurons, we used the MS2-fluorescent repor-
ter RNA localization system to test if endogenous Htt
can be detected in RNA granules that contain BDNF-
3’UTR mRNA (Fig. 1c). This system has been used pre-
viously to investigate the role of an RNA-binding pro-
tein in dendritic transport of target mRNA [16]. Cortical
neurons in culture were transfected with NLS-MS2-
Venus, and an RNA localization reporter plasmid
expressing BDNF-3’UTR fused to the binding sequence
(MS2bs) of the bacteriophage MS2 protein. The BDNF
3’UTR region generates alternative polyadenylated
mRNAs, one ending at 0.35 kb and another at 2.85 kb
downstream of the stop codon [17]. A previous study
reported differential localization of the two BDNF
mRNA populations in neurons; however, the basis for
this phenomenon remains unclear [18]. We examined
three RNA reporter constructs containing full-length
(2.85 kb), short (0.35 kb) and long (2.5 kb) BDNF
3’UTR sequence. Staining for endogenous Htt showed
significant co-localization with all three BDNF-3’UTR
reporters (detected by NLS-MS2-Venus) in cortical den-
drites (Fig. 1d-f). Quantitative analysis of one projection
from the image stack shows 35.7% of short 3’UTR,
38.8% of long 3’UTR and 31.5% of full-length 3’UTR to
co-localize with endogenous Htt. This result suggests
that Htt co-localizes with BDNF-3’UTR mRNA in den-
drites. We did not detect significant differences among
the reporters containing different lengths of the BDNF
3’UTR sequence. Using live-cell imaging, we also exam-
ined the localization of transfected RFP-Htt480-17Q and
BDNF-3’UTR short mRNA (detected by NLS-MS2-
Venus) in cortical neurons (Fig. 2). Htt was found to
co-traffic with BDNF 3’UTR short mRNA in granules
moving from the periphery towards the cell soma, indi-
cating that Htt may be involved in retrograde dendritic
trafficking of BDNF mRNA through its 3’UTR (Fig. 2
and additional file 1).
Improved method to co-localize endogenous proteins
with RNA in brain tissue
To study the co-localization of Htt and associated pro-
teins with specific mRNAs in the brain, we used immu-
nofluorescence staining (IFS) and FISH. Because of the
problems in applying both FISH and IFS to thick vibra-
tome-generated sections of rat brain tissue, and the lim-
ited sensitivity and high background of most methods,
we employed a new approach using three-dimensional
(3D) reconstruction on serial confocal images to visua-
lize mRNA and proteins at high resolution. This 3D
reconstruction avoids time-consuming and tedious tis-
sue section processing and provides an accurate distri-
bution of mRNA and proteins while retaining their
status in situ.
A series of optimization and troubleshooting steps,
described in Table 1, was carried out to maximize the
signal detection in tissue sections. For combined FISH
and IFS of thick vibratome sections, one challenge is to
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Page 2 of 15Figure 1 Co-localization of endogenous Htt with BDNF mRNA in rat cortical neurons. (a) Monoclonal a-Htt antibody (MAB2166, Millipore)
is highly specific and demonstrates the broad subcellular distribution of full length Htt. Western blot of mouse brain fractions prepared by
sequential centrifugation of total brain homogenate (see Methods) and probed with MAB2166. Htt is present in nuclear (P1), membrane-
associated (P2), large cytoplasmic particles (P3), and soluble pools (S3) of protein. This broad distribution of Htt protein is in agreement to
previously published observations seen with a different antibody (rabbit antibody AP78 against N-terminal peptide, [42]). (b) Co-localization of
endogenous Htt (green) with endogenous BDNF mRNA (red) in DIV 8 rat cortical neurons. Scale bar: 10 μm. (c) A schematic of the MS2-based
mRNA detection system. BDNF-3’UTR positioned downstream of MS2 binding sites is detected by the fluorescently tagged NLS-MS2-Venus
protein by microscopy. (d-f) Co-localization of endogenous Htt with BDNF 3’UTR mRNA in rat cortical neurons. BDNF 3’UTR linked to MS2 is
detected by the co-expressing NLS-MS2-Venus, which is shown in green, and endogenous Htt in red (Cy3). Htt co-localizing with BDNF mRNA
appears yellow in merged images. BDNF mRNA reporter construct with short 3’UTR (400 bases), long 3’UTR (2.6 kb) and full-length 3’UTR (3 kb)
are shown in (d), (e) and (f), respectively. Scale bar: 10 μm, P: proximal.
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effective diffusion of probes for greater access to target
mRNA and antigen. We found treatment with 0.25%
Triton X-100 overnight at 4°C, or 2 hours at room tem-
perature was effective in enhancing permeability of the
sections (up to 30 μm) resulting in the immunodetec-
tion of intracellular proteins such as Ago2 and dynein.
To detect low copy mRNAs (minimal 10-20 copies) in
neurons, we developed a detection system utilizing poly-
clonal chicken a-digoxigenin (DIG) and goat a-chicken
antibodies. We found that the use of tyramide signal
amplification to enhance signal detection [18,19]
required multiple blocking and incubation steps and dis-
played low resolution. In our method, FISH detection of
BDNF mRNA could be performed with protein detec-
tion simultaneously without additional steps. We have
utilized our improved approach to study the co-localiza-
tion of the proteins Htt, Ago2, cytoplasmic polyadenyla-
tion element-binding protein 1 (CPEB1) and dynein,
with BDNF mRNA as described below.
Figure 2 Co-trafficking of Htt with BDNF 3’UTR mRNA in rat cortical neurons. (a) The BDNF mRNA reporter plasmid with short 3’UTR was
co-transfected with plasmids expressing NLS-MS2-Venus and RFP-Htt480-17Q and examined by live-cell imaging. BDNF mRNA is shown in green
(detected by NLS-MS2-Venus) and Htt in red. Htt co-localizing with BDNF mRNA is in yellow in merged images. (b) Four cropped images from a
time-lapse series in (a) captured over 310.5 seconds. Htt is shown in grayscale and the merged image in yellow. Vertical white line is drawn
through the four panels to highlight the movement of one mRNA granule (left of the white line) over time. The distance that the granule
traveled was 1.76 μm. Scale bar: 10 μm.
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Due to the localization of BDNF mRNA in somato-den-
dritic compartments in the hippocampus and cortex
[20,21] and its prominent relationship with Htt, we uti-
lized new enhancements to carry out both FISH and IFS
together. To detect BDNF mRNA, DIG-labeled DNA
probes were generated from a plasmid containing BDNF
3’UTR (see Methods). After hybridization, vibratome
sections were probed with a-Htt and a-Ago2 antibodies.
A representative 3D projection image is shown in Fig.
3a. No FISH signal was observed with probes generated
from the control vector only plasmid (Fig. 3b). Using
the co-localization analysis function of the Zeiss LSM
software, we quantified percent co-localization of BDNF
mRNA, Htt and Ago2 proteins in the P11 rat brain cor-
tex (Fig. 3c). We found co-localization percentage for
each pair of proteins and protein-mRNA ranging
between 12 and 25%.
Seven-color segmentation
Combined multicolor FISH and IFS represent a powerful
way of visualizing the spatial and temporal relationship
between mRNA and proteins in histological sections.
However, for better visualization and interpretation of
the image data, an automatic color segmentation method
is needed. Because showing seven colors in one compo-
site image is difficult for further analysis, color segmenta-
tion should be ideally made to generate six or seven
pseudo channels, each of which representing a specific or
a co-localizing target. In this study, a vector-based seven-
color segmentation approach was applied on one compo-
site image (Fig. 4a-b) from a 3D projection and the seven
pseudo-channels were generated (Fig. 4c-d). The yellow
channel represents co-localizing puncta of BDNF mRNA
and Htt, the magenta channel co-localizing puncta
of BDNF mRNA and Ago2, and the cyan channel co-lo-
calizing Htt and Ago2. The seventh pseudo channel is
s h o w ni np a n e ld :w h i t es i g n a l is the color addition pro-
duct of three primary colors green, red and blue, repre-
senting the co-localization of Htt, BDNF mRNA and
Ago2. Thus, this method offers visualization of the in situ
location of protein pairs or protein and RNA from a sin-
gle image.
Visualization of Htt, CPEB1, dynein with BDNF mRNA
To extend these findings, the expression of BDNF mRNA
was analyzed with Htt and CPEB1, a protein responsible
for recognition of cytoplasmic polyadenylation elements
Table 1 Troubleshooting Guidelines
Problem Possible reason Solution
No or weak hybridization signal Probe degradation Check probe on DNA gel.
If necessary, synthesize new probe.
Probe concentration too low Use more probe.
Use longer hybridization time.
mRNA degradation Optimize perfusion and post-fixation conditions.
Ensure that solutions, containers and instruments are RNase-free.
Inadequate immunofluorescent detection of
DIG-labeled probes
Titrate anti-hapten antibody.
Replace with new antibody.
Replace with more sensitive detection system (e.g. polyclonal
anti-hapten).
Use brighter fluorescent dye conjugated antibodies (e.g. Dylight).
FISH signal detected on section
surface only
Poor permeabilization Use longer incubation time or optimize detergent concentration.
Use thinner sections.
Use shorter probe or oligonucleotide probe.
Non-specific and/or high
background staining
Probe not well purified Optimize purification steps.
Hybridization conditions not optimal Reduce time of hybridization.
Reduce probe amount.
Increase time and volume of post-hybridization washes.
Increase concentration of serum in blocking steps.
Use 4°C for incubation with secondary antibodies.
Use gentle shaking for hybridization, washing steps.
Avoid sections drying out.
Hybridization of probes to unwanted mRNAs Use coding sequence only instead of entire plasmid or shorter
sequence for probe generation.
Use sequence-specific probes.
Use oligonucleotide probes.
Immunofluorescent detection of DIG-labeled
probes not optimal
Adjust concentration of anti-DIG and/or anti-chicken antibodies.
Spin antibody before use.
Use another detection system.
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reconstruction results are shown in Fig. 5a-b and addi-
tional file 2. The 3D temporal and spatial relationship
and the co-localization of individual BDNF mRNA-
containing granules with Htt and CPEB1 in vibratome
sections were demonstrated by high-resolution recon-
struction (Fig. 5c and additional file 3). Quantitative ana-
lysis of one projection from the CPEB1 image stack was
as follows: 37.6% of BDNF mRNA co-localized with
CPEB1, 17.1% of CPEB1 co-localized with BDNF mRNA,
20.0% of Htt co-localized with CPEB1, and 22.0% CPEB1
co-localized with Htt. These results confirm that Htt and
BDNF mRNA are in close proximity to the machinery
involved in RNA processing.
Previous investigations indicated that Htt and dynein
subunits directly interact [22,23], and that Htt plays a
Figure 3 Visualization of BDNF mRNA with Htt and Ago2 proteins in vibratome sections of a P11 rat brain cortex. (a) A 3D projection
of serial optical sections obtained by confocal microscopy. BDNF mRNA, Htt and Ago2 are shown in red, green and blue, respectively.
Reconstruction method: LSM software, optical slice interval: 0.5 μm, stack size: 6.0 μm, N: nucleus, S: soma. White arrow indicates one
co-localizing puncta of BDNF mRNA with Htt and Ago2. Scale bar: 5 μm. (b) Control FISH with a nick-translated probe generated from a control
plasmid. DIC: differential interference contrast. Scale bar: 5 μm. (c) Percent co-localization of BDNF 3’UTR mRNA with Htt and Ago2. 16.6% and
18.1% of Htt was found to co-localize with BDNF mRNA and Ago2, respectively. 14.8% and 12.2% of BDNF mRNA was found to co-localize with
Htt and Ago2, respectively.
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Page 6 of 15Figure 4 Seven-color segmentation of a composite confocal image (3D projection) to analyze mRNA/protein and protein/protein
co-localization in a rat brain slice. Scale bar: 10 μm. (a) Composite image (merged from three channels) taken from Fig. 3a. BDNF mRNA, Htt
and Ago2 are shown in red, green and blue, respectively. (b) An artificial presentation of (a) to demonstrate distribution of different color pixels
in (a). (c) Image in (a) was segmented using self-programmed software integrated in ImageJ to generate seven pseudo channels, each of which
represents single or co-localized target(s). The secondary colors yellow, cyan and magenta indicate overlap of green (Htt) and red (mRNA), green
(Htt) and blue (Ago2), red (mRNA) and blue (Ago2), respectively. The seventh pseudo channel is shown in (d). N: nucleus, S: soma. (d) White
signal is the color addition product of three primary colors green, red and blue, representing co-localization of Htt, BDNF mRNA and Ago2. Due
to the limitations in the co-localization analysis function of the LSM software for confocal microscope, we can calculate percent localization for
double but not triple co-localization.
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proteins [24]. Although transport of BDNF protein
occurs in an anterograde and retrograde manner [25],
there is little information with regard to the localization
of BDNF mRNA in structures associated with microtu-
bule-based molecular motors. To confirm the interac-
tion of Htt and dynein and extend the analysis to BDNF
mRNA, we carried out nick-translation of the BDNF
coding sequence DNA in order to detect BDNF mRNA
in rat brain sections. The sections were subsequently
probed with a-Htt and a-dynein (HC) antibodies.
One representative image of a two-dimensional
(2D) optic slice is shown in Fig. 6a-b. The results of co-
localization analysis of BDNF mRNA and dynein are
shown in Fig. 6c. Using the same method described for
Ago2 (Fig. 3), the co-localizing puncta of Htt/mRNA/
dynein were quantified (Fig. 6g). We found 9.3% of
BDNF mRNA to co-localize with Htt and 4.6% of
dynein to co-localize with Htt. Using the LSM software,
the image stack was reconstructed; one 3D projection is
shown in Fig. 6d-e. For visualizing the co-localization
events in 3D, the whole image stack was segmented and
then reconstructed with the LSM software (Fig. 6f). The
combinatorial approach including multicolor FISH/IFS
and associated co-localization analysis indicates that Htt
and dynein can be found in close proximity to BDNF
mRNA.
Discussion
Previous studies have indicated that Htt serves as a scaf-
fold protein during the process of axonal transport of
BDNF [7]. Anterograde transport of BDNF from the
cortex provides trophic support to striatal neurons. Lack
of cortical BDNF gives rise to atrophy and death of
striatal cells [26]. In addition to axonal transport of
BDNF, transcription of the BDNF gene was also
reported deregulated in Huntington’s disease [7,8].
Reduced BDNF levels lead to a higher susceptibility of
neurons to cell death in several neurodegenerative dis-
eases including HD [27] and Alzheimer’s disease [28].
An emerging regulatory mechanism suggests that target-
ing of BDNF mRNA occurs in specific dendritic sites
after changes in neuronal activity or high frequency sti-
mulation [29]. Although BDNF mRNA in cortical den-
drites will not reach the striatum, changes in cortical
BDNF levels could affect survival of striatal cells. Den-
dritic translation of BDNF mRNA can regulate morpho-
logical changes in spines [12]. The rodent BDNF gene is
Figure 5 Visualization of BDNF mRNA with Htt and mRNA-binding protein CPEB1 in vibratome sections of a rat brain cortex. (a) In
merged panels, BDNF mRNA, Htt and CPEB1 were imaged in red, green and blue, respectively. The three left hand columns are presented in
black and white. Reconstruction method: ImageJ, optical slice interval: 0.5 μm, stack size: 16.0 μm, rotation angle: 0°. N: Nucleus (b) Image stack
in (a) was cropped for high-resolution 3D reconstruction. Yellow arrow indicates one co-localizing puncta of BDNF mRNA with Htt and CPEB1.
Co-localized spots appear white in the merged panel. N: Nucleus. (c) High-resolution 3D presentation of (a) to demonstrate spatial relationship
of Htt/BDNF mRNA/CPEB1. Rotation angle: 170°. Htt, BDNF mRNA and CPEB1 correspond to 1, 2, 3, respectively. Co-localization of Htt/mRNA
(yellow), mRNA/CPEB1 (magenta), Htt/CPEB1 (cyan) and Htt/mRNA/CPEB1 (white) correspond to 4, 5, 6, 7, respectively.
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Page 8 of 15transcribed by multiple promoters and generates at least
22 different transcripts [30,31]. The function of each
mRNA isoform has yet to be characterized. One hypoth-
esis is that different BDNF mRNAs are directed to dif-
ferent subcellular locations and may be locally translated
and released, providing a means to selectively regulate
dendritic architecture in restricted domains [21].
We previously reported that Htt co-localizes with
Ago2 in processing (P)-bodies of somatic cells and neu-
ronal granules [9,10] suggesting that Htt may play a role
in RNA processing and/or gene silencing. To determine
if Htt co-localizes with specific mRNAs in neuronal
granules, which are structurally and functionally related
to P-bodies [32], we utilized multicolor IFS and FISH
techniques in concert with 3D co-localization to follow
the expression of individual molecules in rat brain. We
performed co-localization analysis on neurons and
vibratome sections to study the interaction of proteins
with BDNF mRNA. This is a number-based analysis; i.e.,
we analyze co-localization of BDNF mRNA granules and
Figure 6 Visualization of BDNF mRNA with Htt and dynein in vibratome sections of a rat brain cortex. White arrow indicates
co-localization of BDNF mRNA with Htt and dynein in the images, while yellow arrow indicates co-localization of BDNF mRNA with Htt and
dynein in the diagram. Co-localized spots appear white in the merged panel. N: Nucleus. (a) An optic slice from confocal microscopy. BDNF
mRNA, Htt and dynein are shown in red, green and blue, respectively. Scale bar: 10 μm. (b) A diagram showing intensity profile of pixels
underlying the white line drawn in the merged panel in (a). (c) Co-localization analysis of BDNF mRNA and dynein using the LSM software.
(d) 3D projection of image stack of 37 optical slices. Reconstruction method: LSM software, optical slice interval: 0.5 μm, stack size: 18.0 μm,
rotation angle: 0°. (e) Intensity profile of pixels underlying the white line drawn in the merged panel in (d). (f) 3D co-localization analysis of
mRNA and dynein in image stack. The pixels in red channel (mRNA) and blue channel (dynein) were segmented using a 2D thresholding
approach of the whole stack and segmented stacks were reconstructed using the LSM software. One projection at rotation angle 0°is shown.
(g) Percent co-localization of BDNF mRNA (exon 2c, 4, 6, 8, 9) with Htt and dynein.
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based analysis, which represents the total amount of
mRNA molecules present in the granules. The discovery
that BDNF mRNA is associated with Ago2 and Htt sug-
gests a new mechanism for BDNF gene expression
mediated through mRNA processing in neuronal
granules.
Post-transcriptional control of BDNF mRNA in the
brain likely plays a role in the production of BDNF pro-
tein [29]. While little is known about BDNF mRNA pro-
cessing in neuronal granules, mechanisms of dendritic
trafficking of BDNF mRNA are starting to emerge.
A recent study showed that the mutation G196A
(Val66Met) in the BDNF coding sequence, which is
linked to impaired episodic memory and depression in
humans, disrupts a recognition site in BDNF mRNA for
the RNA-binding protein translin [13]. Reduced binding
by translin at the 196A site was found to block traffick-
ing of (Met)-BDNF mRNA in dendrites. Remarkably, it
was previously reported that Met-carrier mice have
reduced dendritic arborization and display more anxi-
ety-like behavior similar to that of humans [33,34].
Thus, impairment of BDNF mRNA sorting and proces-
sing is likely involved in the pathogenesis of specific
neuronal diseases such as HD and other psychiatric dis-
orders. Indeed, the results shown in the present study
represent a first clue that normal Htt may function in
post-transcriptional repression pathways of BDNF
mRNAs through P-bodies/neuronal granules and its ret-
rograde dynein-mediated transport in dendrites. Further
studies are warranted to determine how mutant Htt
affects BDNF mRNA trafficking and RNA processing.
Combined multicolor FISH and IFS represent a
powerful way of visualizing the spatial relationship
between mRNA and proteins in histological sections. In
this study, several experimental conditions have been
optimized in order to perform mRNA FISH on brain tis-
sue sections. First, brain sections need to be well fixed
so that the low copy target mRNAs are protected and
retained in their native location. Second, the sections
need be properly processed to improve permeability,
enabling probes and antibodies to reach their target.
Treatments with proteinase K, sodium borohydride,
ethanol gradient, or methanol have been previously
applied for preprocessing tissue sections for FISH
[18,35-37]; however, these steps are time-consuming
and may have negative effects on signal detection.
Third, to enhance the signal detection in tissue sections,
methods such as tyramide signal amplification may be
necessary [18,19]. Indeed, a combination of FISH and
IFS may be difficult because immunodetection signal is
likely weaker following FISH.
Using a number of improvements that address these
shortcomings, we were able to visualize at high
resolution the co-localization of BDNF mRNA with Htt
and Ago2 at a single neuron level. These results suggest
that Htt may play a role in post-transcriptional trans-
port/targeting of mRNA through association with neu-
ronal RNA granules. The targeting/trafficking of mRNA
is a complex and dynamic process. The RNA-containing
granules contain multiple proteins including Htt, RNA-
binding proteins, motor proteins, and microtubules.
Assembly/disassembly of protein/protein and protein/
RNA complexes likely occur through multiple signaling
pathways. Therefore, it is difficult to know whether the
observed small percentage of BDNF mRNA co-localizing
with Ago2 and Htt suggests involvement of a labile
component. We also demonstrated the co-localization of
Htt and BDNF mRNA with dynein, a motor protein
involved in retrograde transport of cargos including
mRNA [38]. We have also demonstrated that the 3’UTR
of BDNF mRNA and Htt co-localize and co-traffic in
cortical neurons. Together these findings implicate a
role for Htt in maintaining neurotrophic support and
neuron survival via delivery and processing of BDNF
mRNA.
Conclusions
We report the co-localization of BDNF mRNA with Htt,
Ago2, CPEB and dynein in cultured cortical neurons
and the rat cortex. Our combined approach of IFS/FISH
and co-localization analysis provides a powerful means
to study protein-mRNA interaction in neuronal cells or
tissues. We show that the 3’UTR of BDNF mRNA and
Htt co-localize and co-traffic in cortical neurons. These
results suggest that Htt may play a role in post-tran-
scriptional transport/targeting of mRNA through asso-
ciation with neuronal RNA granules. The findings
implicate a role for Htt in maintaining neurotrophic
support and neuron survival via delivery and processing
of BDNF mRNA.
Methods
Brain fractionation
Brain fractions were generated as described [39]. Briefly,
one flash frozen P15 Swiss Webster mouse brain was
minced into a paste and homogenized on ice in a glass
Dounce homogenizer in 2 ml of Buffer A (10 mM
H E P E S ,p H7 . 6 ;1 . 5m MM g C l 2) containing protease
inhibitors (leupeptin, pepstatin, aprotinin, PMSF, and
sodium metabisulfite) and RNAse inhibitor (40 units
RNAsin, Promega). The homogenate was incubated on
ice for 10 minutes after which 1/10 volume of 10 × Buffer
B (300 mM HEPES, pH 7.6; 1.4 M KCl, 30 mM MgCl2)
was added. Homogenate was spun at 1,400 × g for 10
minutes at 4°C to pellet the P1 fraction. The P1 fractions
were washed in 1 ml of 1 × Buffer B and spun as before.
The combined supernatants from the 1,400 × g spin were
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fraction. The supernatant (S2) was spun for an additional
2 hours at 100,000 × g at 4°C to pellet the P3 fraction.
Fraction P1 was resuspended in one-half the volume of
total S3, fraction P2 was resuspended in same volume as
total S3, and fraction P3 was resuspended in 1/10 volume
of total S3. 50 mg of S3 and equivalent volumes of P1,
P2, and P3 fractions were loaded onto a 7.5% SDS polya-
crylamide gel for electrophoresis.
Western blotting
50 μgo fS 3a n de q u i v a l e n tv o l u m e so fP 1 ,P 2 ,a n dP 3
fractions were loaded onto a 7.5% SDS polyacrylamide
gel for electrophoresis and transferred to nitrocellulose
membrane, blocked for 1 hour in 5% nonfat dry milk in
TBST at room temperature, and incubated in a 1:1000
dilution of MAB2166 (Millipore) in TBST overnight at
4°C. IR Dye 800 conjugated goat anti-mouse secondary
antibody was used at 1:10000. Blot was scanned on a
LI-COR Odyssey infrared scanner (LI-COR, Lincoln,
NE).
Preparation of nick-translated probes
DIG-labeled DNA probes were generated using DIG-
Nick Translation Mix (Roche Applied Science) accord-
ing to manufacturer’sp r o t o c o l .1 . 0μg RLTK plasmid
DNA (Promega) containing BDNF 3’UTR only, or
1.0 μg of a mixture of plasmid DNA each (0.25 μg) con-
taining exon2c, exon4, exon6, or exon8 of the BDNF
gene linked to the protein coding sequence (exon9) of
BDNF and fused with GFP at the 3’ end [13]. The latter
probe mix was used to detect “BDNF mRNA” in the
current study. RLTK plasmid without any insert was
used as a control. After nick-translation, Illustra Probe-
Quant™ G-50 Micro Columns (GE Healthcare) were
used for probe purification. 1.0 μg template DNA
yielded 50 μl of probe. Probes of 200-400 bp in length
were used for hybridization.
Preparation of vibratome sections
Female wild-type Wistar rats (2 or 3 weeks old, Harlan
Laboratories, Indianapolis, IN) were perfused transcar-
dially with PBS (pH 7.4), followed by 4% paraformalde-
hyde (PFA, Electron Microscopy Sciences, Hatfield, PA)
under deep anesthesia induced by i.p. injection of a mix-
ture of ketamine (100 mg/kg) and xylazine (25 mg/kg).
Brain tissues were extracted from the skull, post-fixed
with 4% PFA/20% sucrose for at least two days at 4°C.
All rats were maintained under veterinary supervision at
New York University School of Medicine Animal Care
Facility in accordance with the guidelines established by
the NIH for the care of laboratory animals and all pro-
cedures approved by the Institutional Animal Care and
Use Committee. 100 μm vibratome sections were
prepared with a Vibratome Series 1000 Classic (Vibra-
tome Company, St. Louis, MO) and transferred to
24-well plates filled with DEPC-PBS.
Fluorescence in situ hybridization of mRNA
DEPC-treated water was used for preparation of PBS and
other reagents. The sections were treated with 0.25% Tri-
ton X-100 in PBS overnight at 4°C and washed 3 times
with PBS. After 20 minute rinsing in 1 × SSC, the sec-
tions were incubated for 2 hours at 37°C with 100 μl
hybridization buffer [25% dextran sulfate, 30 μg/ml single
stranded salmon sperm DNA (Sigma), 30 μg/ml yeast
tRNA (Sigma), 0.4% bovine serum albumin (Jackson
ImmunoResearch Laboratories), 20 mM ribonucleoside
vanadyl complex (Sigma), 0.01 M sodium phosphate buf-
fer (pH 7.0), 2 × SSC]. The sections were then hybridized
for 12 hours at 37°C with 5 μl of nick-translated probe
diluted in 100 μl hybridization buffer. After hybridization,
sections were washed with 40% formamide/1 × SSC for
1h o u ra t3 7 ° Cw i t hg e n t l es h a k i n g ,f o l l o w e db y3×3 0
minute washing with 1 × SSC with gentle shaking on an
orbital shaker.
Detection of DIG-labeled probes and immunofluorescence
staining
Primary antibodies used in the study are listed in Table 2.
All dilutions and washes (3 × 30 minutes) between stages
were performed in PBS unless otherwise stated. Vibra-
tome sections were washed for 20 minutes in PBS,
blocked with 5% goat serum (Sigma) for 2 hours, and
incubated overnight at 4°C with primary antibodies (in
solution containing 5% goat serum). They were then
incubated overnight at 4°C with secondary antibodies.
After immunolabeling, they were transferred to Lab-Tek
2-well chamber cover glass (Nalge Nunc International)
for analysis. For improved observation, a piece of cover
slip (12 mm) was placed over the section to anchor it to
the bottom of the chamber cover glass. Detection of
DIG-labeled probes was carried out by incubating sec-
tions with chicken a-DIG antibody (Immunology Con-
sultants Laboratory, Newberg, OR), followed by
incubation with Dylight 549-conjugated goat a-chicken
IgY (IgG) (Jackson ImmunoResearch Laboratories). Htt
was detected by incubating sections with mouse a-Htt
(Millipore), followed by Alexa 488-conjugated goat a-
mouse IgG (Invitrogen). Ago2, dynein and CPEB1 were
detected by incubating sections with rabbit a-Ago2 (gift
of Ramin Shiekhattar, The Wistar Institute, PA), rabbit
a-dynein HC (Santa Cruz Biotechnology) and rabbit
a-CPEB1 (gift of David Wells, Yale University) antibo-
dies, followed by Dylight 649-conjugated goat a-rabbit
IgG (Jackson ImmunoResearch Laboratories). FISH of
primary neurons was performed with a similar procedure
with less processing time for incubation and washing.
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Confocal imaging was performed using an LSM 510
META confocal scanning laser system on an Axiovert
200 M microscope (Carl Zeiss). The instrument settings
are detailed in Table 3. Images were acquired with a
Plan-Apochromat 100 ×/1.3 oil-immersion objective
lens, which can reduce the chromatic shift. Brightness
and contrast of images were adjusted before export to
Adobe Photoshop CS for further processing. Co-locali-
zation analysis was performed using the co-localization
function in the LSM software. Punctate regions of fluor-
escence intensity are defined as focal areas of intensity
greater than the average local background fluorescence
plus two times the standard deviation. In Photoshop,
puncta staining in neurons were counted manually in
either 2D image or 3D projection image. Total events
were obtained by multiplying the average number for
each square by the number of squares. Percent co-locali-
zation was calculated by dividing the co-localization
events by the total number of events. The following pre-
cautionary steps were taken to ensure accuracy. The
results generated by the software were first compared
with the original images to confirm the presence of co-
localizing spots. Only a certain percentage (greater than
30%) of overlap was recognized as co-localization spots.
Too little overlap of two targets, which appeared as very
small spots in merged images, was not regarded as co-
localization. A large sample size (more than 1500
puncta) was also used to improve accuracy of the
analysis.
Seven-color segmentation
Segmentation was performed using a modified version
of the formerly described program [40]. The principle of
this approach is in the classification of each pixel into
one of seven colors (red, green, blue, yellow, magenta,
cyan and white) by choosing the minimal angular devia-
tion between the RGB vector of a given pixel and seven
classically defined edge vectors. White was defined as
(255, 255, 255) in RGB color model. Briefly, background
was subtracted from the image and color segmentation
was performed using a program integrated in ImageJ
platform. After segmentation, images in seven pseudo
channels were changed to grayscale and assigned seven
defined colors. Finally, the images were smoothed and
processed in ImageJ to generate a final version of seven
pseudo channels, each of which represents one target or
co-localization of two or three targets.
Table 2 Antibodies used in the study
Antibody Immunogen Source Host
species
Isotype, Dilution used
anti-DIG digoxigenin conjugated with KLH Immunology Consultants
Laboratory, CDIG-65A
chicken polyclonal IgY, 1:500
anti-Htt human huntingtin protein a.a.
181-810
Millipore, MAB2166 mouse monoclonal, IgG1,
clone 1HU-4C8, 1:500
anti-Ago2 human Ago2 peptide
KLMRSASFNTDPYVRE
Gift of Ramin Shiekhattar, The
Wistar Institute
rabbit polyclonal, 1:1000
anti-dynein HC rat dynein heavy chain a.a.
4320-4644
Santa Cruz Biotechnology, sc-9115 rabbit polyclonal, IgG, 1:300
anti-CPEB1 mouse CPEB1 peptide
SMEGLRHHSPLMRNQKN
Gift of David Wells, Yale University rabbit polyclonal, IgG, 1:1000
Alexa Fluor® 488 goat anti-
mouse IgG
mouse IgG (H + L) Invitrogen, A-11001 goat polyclonal, 1:500
Cy3 goat anti-mouse IgG mouse IgG (H + L) Jackson ImmunoResearch,
115-166-003
goat polyclonal, F(ab’)2 fragment,
1:500
DyLight 549 goat anti-
chicken IgY (IgG)
chicken IgY (IgG) (H + L) Jackson ImmunoResearch,
103-505-155
goat polyclonal, 1:500
DyLight 649 goat anti-rabbit
IgG
rabbit IgG (H + L) Jackson ImmunoResearch,
111-495-144
goat polyclonal, 1:500
Abbreviations: DIG, digoxigenin; KLH, keyhole limpet hemocyanin; Htt, huntingtin; Ago, Argonaute; CPEB, cytoplasmic polyadenylation element binding protein
Table 3 Parameters and settings used for confocal microscopy
Fluorescent dye Laser Excitation wavelength (nm) Emission filter (nm) Detector
Alexa 488 Argon (max.12%) 488 BP 505-530 Normal
Dylight 549, Cy3 HeNe1 (max. 29%) 543 BP 560-615 Normal
Dylight 649 HeNe2 (max. 44%) 633 659-723 META
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(a) 3D reconstruction with LSM software
The 3D projection and reconstruction were performed
with Projection function in the 3D View menu. Projection
method: maximum; rotation: along y-axis; total projec-
tions: 64.
(b) 3D reconstruction with Image J
ImageJ 1.42 http://rsb.info.nih.gov/ij/ was obtained from
the National Institutes of Health. Stacks of images from
optical sections were exported to ImageJ as serial
images, processed, and saved as TIFF image sequence.
3D projections were performed using image sequence,
and the movies generated were saved as uncompressed
AVI files. The settings for 3D projection were: rotation
angle increment: 10; opacity: 0; surface depth-cueing:
100%; interior depth-cueing: 50%; projection methods:
brightest point; interpolate: selected. The slice spacing
was calculated using the scale relationship of x- and z-
axis. For example, if a 90 μm×9 0μmi m a g eh a sas i z e
of 512 × 512 pixels and optical section interval is 0.5
μm, the slice spacing is 2.84 pixels (512 × 0.5/90).
(c) Compression of movie files
Movie files were compressed with Virtual Dub (Version
1.9.0.0, http://www.virtualdub.org) and saved as AVI.
Cinepak Codec by Radius was used for compression.
BDNF-3’UTR reporter plasmids
The MS2 binding sites of the bacteriophage MS2 pro-
tein were cloned downstream of the Renilla luciferase
gene in pRL-TK vector (Promega). Full-length (2.85 kb),
short (0.35 kb) or long (2.5 kb) 3’UTR sequence of the
mouse BDNF gene was amplified by PCR of a genomic
DNA clone (gift of Lino Tessarollo) and inserted down-
stream of the MS2 binding sites to generate the three
BDNF-3’UTR reporter constructs.
Transfection of primary neurons
Rat cortical neurons were isolated and cultured as pre-
viously described [41]. Neurons were fixed with 4% PFA in
PBS for 20 minutes at room temperature. Rat cortical neu-
rons of DIV5 were typically transfected with 1 μgt o t a l
plasmid DNA with 1 μl of Lipofectamine 2000 (Invitrogen)
in OptiMEM (Invitrogen) per 24 well as recommended by
the manufacturer. Transfection of 0.5 μg NLS-MS2-Venus
[16] and 0.5 μgo fo n eo ft h r e eB D N F3 ’UTR constructs
were used for visualization of BDNF mRNA in neurons.
Before transfection, 50% of culture medium was removed
and later used to replace the medium after 1-hour incuba-
tion with the transfection mixture. Neurons were fixed
and immunostained 18-24 hours after transfection. Htt
was detected by incubating cells with mouse a-Htt (Milli-
pore), followed by Cy3-conjugated goat a-mouse IgG
(Jackson ImmunoResearch Laboratories).
Live cell imaging
For imaging of BDNF mRNA in live cells, 0.33 μgo f
NLS-MS2-Venus, 0.33 μgo faB D N F3 ’UTR plasmid
and 0.33 μg mRFP-Htt480-17Q [9] were transfected
per well in a 24-well plate. 18-24 hours after transfec-
tion, neurons were transferred to Lab-Tek 2-well
chamber cover glass (Nalge Nunc International) for
live cell imaging. Less laser power (3% for Argon laser
and 10% for HeNe1) was used to avoid photobleaching
and toxicity. Frame time was 15 seconds and frame
interval 5.0 seconds. Images were acquired with a
Plan-Neofluar 40 ×/1.3 oil-immersion objective lens.
T h ei m a g e sw e r ee x p o r t e da n dam o v i ef i l eg e n e r a t e d
by ImageJ.
Additional file 1: Co-trafficking of Htt with BDNF short 3’UTR in rat
cortical neurons was imaged live over 610.2 seconds. BDNF 3’UTR
mRNA (detected by NLS-MS2-Venus) is in green and RFP-Htt480-
17Q in red. Co-localization of Htt with BDNF 3’UTR is shown in yellow in
the merged image.
Additional file 2: Simultaneous visualization of BDNF mRNA with
Htt and mRNA-binding protein CPEB1 in vibratome sections of rat
brain cortex. BDNF mRNA, Htt and CPEB1 are shown in red, green and
blue, respectively. Reconstruction method: ImageJ; optical slice interval:
0.5 μm; stack size: 16.0 μm.
Additional file 3: High-resolution visualization of temporal and
spatial relationship and interaction of BDNF mRNA with Htt and
CPEB1 in vibratome sections of rat brain cortex. Htt, BDNF mRNA
and CPEB1 are indicated with number 1, 2, 3, respectively. Co-localization
of Htt/mRNA (yellow), mRNA/CPEB1 (magenta), Htt/CPEB1 (cyan) and
Htt/mRNA/CPEB1 (white) are indicated with 4, 5, 6, 7, respectively.
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